Insertion/deletion polymorphism in clusterin gene influences serum lipid levels and carotid intima-media thickness in hypertensive Japanese females

Biochemical and Biophysical Research Communications

Volumn 331, Issue 4, 2005, Pages 1587-1593

  Miwa, Yoshikazu ^a,b   Takiuchi, Shin ^a   Kamide, Kei ^a   Yoshii, Masayoshi ^a   Horio, Takeshi ^a   Tanaka, Chihiro ^a   Banno, Mariko ^a   Miyata, Toshiyuki ^a   Sasaguri, Toshiyuki ^b   Kawano, Yuhei ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Apolipoprotein J; Atherosclerosis; Carotid arteries; Clusterin; Hypertension; Polymorphism; Risk factors

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; CLUSTERIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ALLELE; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA POLYMORPHISM; FEMALE; GENE DELETION; GENE INSERTION; GENE MUTATION; GENE SEQUENCE; GENOTYPE; HUMAN; HYPERTENSION; INTIMA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MISSENSE MUTATION; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; BASE SEQUENCE; CAROTID ARTERIES; CLUSTERIN; DNA PRIMERS; FEMALE; GLYCOPROTEINS; HUMANS; HYPERTENSION; LIPIDS; MIDDLE AGED; MOLECULAR CHAPERONES; POLYMORPHISM, GENETIC; TUNICA INTIMA;

EID: 21044454051     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.04.069     Document Type: Article

References (29)

1. M.R. Wilson, and S.B. Easterbrook-Smith Clusterin is a secreted mammalian chaperone Trends Biochem Sci. 25 2000 95 98
2. Y. Ishikawa, Y. Akasaka, T. Ishii, K. Komiyama, S. Masuda, N. Asuwa, N.H. Choi-Miura, and M. Tomita Distribution and synthesis of apolipoprotein J in the atherosclerotic aorta Arterioscler. Thromb. Vasc. Biol. 18 1998 665 672
3. M. Miyata, S. Biro, H. Kaieda, H. Eto, K. Orihara, T. Kihara, H. Obata, N. Matsushita, T. Matsuyama, and C. Tei Apolipoprotein J/clusterin is induced in vascular smooth muscle cells after vascular injury Circulation 104 2001 1407 1412
4. N. Sivamurthy, D.H. Stone, F.W. Logerfo, and W.C. Quist Apolipoprotein J inhibits the migration, adhesion, and proliferation of vascular smooth muscle cells J. Vasc. Surg. 34 2001 716 723
5. C.L. Moulson, and A.J. Millis Clusterin (Apo J) regulates vascular smooth muscle cell differentiation in vitro J. Cell. Physiol. 180 1999 355 364
6. 2-induced vascular smooth muscle cell differentiation Biochem. Biophys. Res. Commun. 319 2004 163 168
7. H.V. de Silva, W.D. Stuart, C.R. Duvic, J.R. Wetterau, M.J. Ray, D.G. Ferguson, H.W. Albers, W.R. Smith, and J.A. Harmony A 70-kDa apolipoprotein designated Apo J is a marker for subclasses of human plasma high density lipoproteins J. Biol. Chem. 265 1990 13240 13247
8. I.C. Gelissen, T. Hochgrebe, M.R. Wilson, S.B. Easterbrook-Smith, W. Jessup, R.T. Dean, and A.J. Brown Apolipoprotein J (clusterin) induces cholesterol export from macrophage-foam cells: a potential anti-atherogenic function? Biochem. J. 331 1998 231 237
9. M.I. Kamboh, J.A. Harmony, B. Sepehrnia, M. Nwankwo, and R.E. Ferrell Genetic studies of human apolipoproteins. XX. Genetic polymorphism of apolipoprotein J and its impact on quantitative lipid traits in normolipidemic subjects Am. J. Hum. Genet. 49 1991 1167 1173
10. C.S. Nestlerode, C.H. Bunker, D.K. Sanghera, C.E. Aston, F.A. Ukoli, and M.I. Kamboh Apolipoprotein J polymorphisms and serum HDL cholesterol levels in African blacks Hum. Biol. 71 1999 197 218
11. B. Tycko, L. Feng, L. Nguyen, A. Francis, A. Hays, W.Y. Chung, M.X. Tang, Y. Stern, A. Sahota, H. Hendrie, and R. Mayeux Polymorphisms in the human apolipoprotein-J/clusterin gene: ethnic variation and distribution in Alzheimer's disease Hum. Genet. 98 1996 430 436
12. S.E. Antonarakis Recommendations for a nomenclature system for human gene mutations. Nomenclature Working Group Hum. Mutat. 11 1998 1 3
13. C. Tanaka, K. Kamide, S. Takiuchi, Y. Miwa, M. Yoshii, Y. Kawano, and T. Miyata An alternative fast and convenient genotyping method for the screening of angiotensin converting enzyme gene polymorphisms Hypertens. Res. 26 2003 301 306
14. I.P. Trougakos, M. Poulakou, M. Stathatos, A. Chalikia, A. Melidonis, and E.S. Gonos Serum levels of the senescence biomarker clusterin/apolipoprotein J increase significantly in diabetes type II and during development of coronary heart disease or at myocardial infarction Exp. Gerontol. 37 2002 1175 1187
15. M. Navab, S. Hama-Levy, B.J. Van Lenten, G.C. Fonarow, C.J. Cardinez, L.W. Castellani, M.L. Brennan, A.J. Lusis, A.M. Fogelman, and B.N. La Du Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio J. Clin. Invest. 99 1997 2005 2019
16. N.H. Choi-Miura, T. Sakamoto, S. Ohtaki, H. Nakamura, S. Ishizawa, Y. Takagi, K. Gomi, and M. Tomita Elevated complement activities of sera from patients with high density lipoprotein deficiency (Tangier disease): the presence of normal level of clusterin and the possible implication in the atherosclerosis Clin. Exp. Immunol. 93 1993 242 247
17. K. Akakura, N. Bruchovsky, P.S. Rennie, A.J. Coldman, S.L. Goldenberg, M. Tenniswood, and K. Fox Effects of intermittent androgen suppression on the stem cell composition and the expression of the TRPM-2 (clusterin) gene in the Shionogi carcinoma J. Steroid Biochem. Mol. Biol. 59 1996 501 511
18. M.G. Bandyk, I.S. Sawczuk, C.A. Olsson, A.E. Katz, and R. Buttyan Characterization of the products of a gene expressed during androgen-programmed cell death and their potential use as a marker of urogenital injury J. Urol. 143 1990 407 413
19. P.W.F. Wilson, E.J. Schaefer, M.G. Larson, and J.M. Ordovas Apolipoprotein E alleles and risk of coronary disease. a mete analysis Arterioscler. Thromb. Vasc. Biol. 16 1996 1250 1255
20. R. Jemaa, F. Fumeron, O. Poirier, L. Lecerf, A. Evans, D. Arveiler, G. Luc, J.P. Cambou, J.M. Bard, and J.C. Fruchart Lipoprotein lipase gene polymorphisms: associations with myocardial infarction and lipoprotein levels, the ECTIM study J. Lipid Res. 36 1995 2141 2146
21. R.A. Carleton, J. Dwyer, L. Finberg, J. Flora, D.S. Goodman, S.M. Grundy, S. Havas, G.T. Hunter, D. Kritchevsky, and R.M. Lauer Report of the Expert panel on population strategies for blood cholesterol reduction. A statement from the National Cholesterol Education Program, National Heart, Lung, and Blood Institute, National Institutes of Health Circulation 83 1991 2154 2232
22. W.H. Berrettini, J. Vuoristo, T.N. Ferraro, R.J. Buono, D. Wildenauer, and L. Ala-Kokko Human G(olf) gene polymorphisms and vulnerability to bipolar disorder Psychiatr. Genet. 8 1998 235 238
23. D. Wang, T. Kanuma, H. Mizunuma, F. Takama, Y. Ibuki, N. Wake, A. Mogi, Y. Shitara, and S. Takenoshita Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer Cancer Res. 60 2000 4507 4512
24. M. Izawa Identification of a transcript predicting an alternative form of sulfated glycoprotein-2 (clusterin) in rat tissues Biochem. Mol. Biol. Int. 44 1998 9 18
25. K.S. Leskov, D.Y. Klokov, J. Li, T.J. Kinsella, and D.A. Boothman Synthesis and functional analyses of nuclear clusterin, a cell death protein J. Biol. Chem. 278 2003 11590 11600
26. K. Kimura, and M. Yamamoto Modification of the alternative splicing process of testosterone-repressed prostate message-2 (TRPM-2) gene by protein synthesis inhibitors and heat shock treatment Biochim. Biophys. Acta 1307 1996 83 88
27. K. Kimura, K. Asami, and M. Yamamoto Effect of heat shock treatment on the production of variant testosterone-repressed prostate message-2 (TRPM-2) mRNA in culture cells Cell. Biochem. Funct. 15 1997 251 257
28. S. Peters, B. Gotting, M. Trummel, H. Rust, and A. Brattstrom Valsartan for prevention of restenosis after stenting of type B2/C lesions: the VAL-PREST trial J. Invasive Cardiol. 13 2001 93 97
29. ACE Inhibitor Myocardial Infarction Collaborative Group, Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials, Circulation 97 (1998) 2202-2212